ExpreS2ion Biotech
在场
ExpreS2ion Biotech 是一家在股票代码 EXPRS2 (DK) 下上市的公司。
高管
查看带有其 8 名主要高管的组织结构图
ExpreS2ion Biotech 搜索最多的简介
- Bent Frandsen, Chief Executive Officer
- Sara Sande, Board Member
- Martin Jensen, Chairman of the Board
创建提醒
跟踪 ExpreS2ion Biotech 的高管变动
生物技术
ExpreS2ion Biotech 拥有 2,332 家竞争者，其中包括 Eurofins (卢森堡)、Lonza (瑞士) 和 Biogen (美国(美洲))。
Popular M&A news in 生物技术
- March Biosciences 刚刚宣布为 28 筹款数百万美元。 (公布2024十二月3号).
- Lyell Immunopharma 已收购 ImmPACT Bio (公布2024十一月29号).
- Hopo Therapeutics 刚刚宣布为 226 筹款数百万美元。 (公布2024十一月29号).
生物技术 行业的其他推荐联系人
消息
ExpreS2ion Biotech 的最新新闻稿
- Press Releases Cision – Expres2ion Biotech
- ExpreS2ion will participate in key investor and industry events in October 2021 - ExpreS2ion Biotechnologies
- Warrants of series TO5 were subscribed to approximately 97.4 percent and ExpreS2ion receives approximately SEK 44.3 million - ExpreS2ion Biotechnologies
- Press kit - ExpreS2ion Biotechnologies
- Last day of trading in warrants of series TO5 is September 16, 2021 - ExpreS2ion Biotechnologies
- ExpreS2ion announces TO5 warrant exercise price and start of subscription period - ExpreS2ion Biotechnologies
- ExpreS2ion will participate in key investor events in September 2021 - ExpreS2ion Biotechnologies
- Pareto Securities and Analysguiden publish research reports with increased price targets of SEK 68 and SEK 55, respectively - ExpreS2ion Biotechnologies
- The ABNCoV2 COVID-19 vaccine program receives up to DKK 800 million from the Danish Ministry of Health - ExpreS2ion Biotechnologies
- ExpreS2ion’s Board and Management committed to fully exercise their TO5 warrants - ExpreS2ion Biotechnologies
- View more press releases Close
通过电子邮件
